SE
Therapeutic Areas
Abbott Pipeline
| Drug | Indication | Phase |
|---|---|---|
| FreeStyle Libre | Diabetes Management (Continuous Glucose Monitoring) | Commercial |
| Lingo Glucose System | General Wellness / Metabolic Tracking (Not for disease diagnosis) | Commercial |
| TriClip G4 System | Tricuspid Valve Regurgitation | Commercial |
| Navitor TAVI | Aortic Stenosis | Commercial |
| MitraClip | Mitral Valve Regurgitation | Commercial |
| AVEIR DR Leadless Pacemaker | Bradycardia | Commercial |
| Alinity Diagnostic System Assays | Various (Infectious Disease, Cancer, Cardiology, etc.) | Development/Commercial |
| Ensure | Nutritional Supplement | Commercial |
Leadership Team at Abbott
RB
Robert B. Ford
Chairman of the Board and Chief Executive Officer
PB
Philip Boudreau
Senior Vice President, Chief Financial Officer
JM
John M. Capek
Executive Vice President, Medical Devices
AF
Andrea F. Wainer
Executive Vice President, Rapid and Molecular Diagnostics
CJ
Christopher J. Scoggins
Senior Vice President, General Counsel and Secretary
MM
Mary Moreland
Executive Vice President, Human Resources
JS
Jared S. Watkin
Senior Vice President, Chief Marketing Officer
RE
Robert E. Funck
Executive Vice President, Established Pharmaceuticals
MB
Michele Buck
Board Member